Year archive

MESOBLAST LTD — 2022 filings

All 135 regulatory filings released by MESOBLAST LTD (MESO) in 2022, sourced directly from the official regulator.

135 Filings

2022 Period

2022 filings (135)

Filing	Released	Lang
PROSPECTUS Capital/Financing Update	2022-12-30	English
6-K Regulatory Filings	2022-12-29	English
Regulatory Filings 2022 Regulatory Filings	2022-12-29	English
Regulatory Filings 2022 Regulatory Filings	2022-12-28	English
PROSPECTUS Capital/Financing Update	2022-12-27	English
Regulatory Filings 2022 Regulatory Filings	2022-12-23	English
Proposed issue of securities - MSB 5 pages 28.8KB Capital/Financing Update	2022-12-22	English
Extension of Undrawn US$30 million Facility 2 pages 160.1KB Capital/Financing Update	2022-12-22	English
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Transaction in Own Shares	2022-12-20	English
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Transaction in Own Shares	2022-12-20	English
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Transaction in Own Shares	2022-12-20	English
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Transaction in Own Shares	2022-12-20	English
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Transaction in Own Shares	2022-12-20	English
REGISTRATION STATEMENT Capital/Financing Update	2022-12-20	English
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3 Transaction in Own Shares	2022-12-20	English
6-K Regulatory Filings	2022-12-07	English
Appendix 3G, Appendix 3H and Appendix 3Y 25 pages 599.8KB Share Issue/Capital Change	2022-12-01	English
6-K AGM Information	2022-11-28	English
6-K Interim / Quarterly Report	2022-11-28	English
Amended Constitution 51 pages 632.0KB Governance Information	2022-11-23	English
First Quarter Financial Results on Form 6-K 85 pages 515.8KB Interim / Quarterly Report Q1 2023	2022-11-22	English
CEO First Quarter Results and 2022 AGM Presentation 29 pages 2.0MB Interim / Quarterly Report Q1 2023	2022-11-22	English
MSB Q1 Financial Results and Operational Highlights 8 pages 452.6KB Interim / Quarterly Report Q1 2023	2022-11-22	English
Long-Term Survival for Acute GvHD Treatment with Remestemcel 3 pages 199.0KB Capital/Financing Update	2022-11-22	English
Chairman's Address to Shareholders 3 pages 189.3KB AGM Information	2022-11-22	English
Results of Meeting 3 pages 187.2KB Declaration of Voting Results & Voting Rights Announcements	2022-11-22	English
Mesoblast First Quarter Financial Results Webcast 1 Investor Presentation	2022-11-20	English
6-K Regulatory Filings	2022-11-16	English
Removal of Amendment to Constitution About Virtual Meetings 2 pages 130.6KB AGM Information	2022-11-14	English
6-K Regulatory Filings	2022-11-07	English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 395.9KB Interim / Quarterly Report Q1 2023	2022-10-30	English
Appendix 4G and Corporate Governance Statement 22 pages 382.8KB Regulatory Filings	2022-10-23	English
Annual Report to Shareholders 240 pages 6.9MB Annual Report FY 2022	2022-10-23	English
Notice of Annual General Meeting and Proxy Form 30 pages 437.9KB AGM Information	2022-10-23	English
6-K Regulatory Filings	2022-10-22	English
Notification of cessation of securities - MSB 4 pages 24.3KB Regulatory Filings	2022-10-13	English
6-K Regulatory Filings	2022-10-05	English
Submits New Information to FDA IND File for SR-aGVHD 3 pages 167.0KB Regulatory Filings	2022-10-02	English
REGISTRATION STATEMENT Capital/Financing Update	2022-09-30	English
6-K Director's Dealing	2022-09-23	English
Change of Director's Interest Notice 2 pages 223.8KB Director's Dealing	2022-09-19	English
6-K Regulatory Filings	2022-09-14	English
Regulatory Filings 2022 Regulatory Filings	2022-09-13	English
Change of Director's Interest Notice 2 pages 221.3KB Director's Dealing	2022-09-11	English
Regulatory Filings 2022 Regulatory Filings	2022-09-08	English
Regulatory Filings 2022 Regulatory Filings	2022-09-07	English
AMENDMENT NO. 8 Major Shareholding Notification	2022-09-06	English
REGISTRATION STATEMENT Capital/Financing Update	2022-08-31	English
6-K Regulatory Filings	2022-08-31	English
20-F Annual Report FY 2022	2022-08-31	English
Preliminary Final Report 239 pages 3.3MB Annual Report FY 2022	2022-08-30	English
Annual Financial Results Presentation 27 pages 1.8MB Annual Report FY 2022	2022-08-30	English
MSB Annual Financial Results and Operational Highlights 8 pages 338.3KB Annual Report FY 2022	2022-08-30	English
Mesoblast 2022 Full Year Financial Results Webcast 1 Investor Presentation	2022-08-29	English
6-K Director's Dealing	2022-08-20	English
Final Director's Interest Notice 2 pages 229.7KB Director's Dealing	2022-08-17	English
Initial Director's Interest Notice 2 pages 314.6KB Director's Dealing	2022-08-17	English
Director Appointment 2 pages 141.4KB Board/Management Information	2022-08-17	English
6-K Regulatory Filings	2022-08-16	English
Change in substantial holding 6 pages 501.9KB Major Shareholding Notification	2022-08-15	English
Ceasing to be a substantial holder from TOP 8 pages 330.5KB Major Shareholding Notification	2022-08-15	English
Ceasing to be a substantial holder from TEK 8 pages 334.9KB Major Shareholding Notification	2022-08-15	English
Ceasing to be a substantial holder - Tiga Trading Pty Ltd 8 pages 316.1KB Major Shareholding Notification	2022-08-15	English
Appendix 2A 22 pages 327.8KB Share Issue/Capital Change	2022-08-11	English
Cleansing Notice 1 page 176.9KB Capital/Financing Update	2022-08-11	English
Reinstatement to Quotation 1 page 89.0KB Regulatory Filings	2022-08-08	English
US$45 Million Private Placement to Major Shareholders 2 pages 164.9KB Capital/Financing Update	2022-08-08	English
Appendix 3B 57 pages 677.0KB Capital/Financing Update	2022-08-08	English
Voluntary Suspension 3 pages 229.0KB Capital/Financing Update	2022-08-07	English
6-K Regulatory Filings	2022-08-05	English
Pause in Trading 1 page 111.3KB Regulatory Filings	2022-08-03	English
Trading Halt 2 pages 213.2KB Capital/Financing Update	2022-08-03	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 419.7KB Interim / Quarterly Report Q4 2022	2022-07-28	English
6-K Regulatory Filings	2022-07-21	English
Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE 4 pages 182.8KB Regulatory Filings	2022-07-18	English
6-K Regulatory Filings	2022-07-14	English
Appendix 3H and Appendix 3Y 6 pages 360.3KB Director's Dealing	2022-07-13	English
Rexlemestrocel-L to be Highlighted on Heart Failure Panel 3 pages 164.6KB Investor Presentation	2022-07-11	English
Chronic Low Back Pain KOL Event Presentation 30 pages 7.2MB Investor Presentation	2022-06-20	English
Mesoblast CLBP Event with Key Opinion Leaders 3 pages 165.8KB Investor Presentation	2022-06-20	English
6-K Regulatory Filings	2022-06-17	English
Litigation Update 2 pages 171.1KB Legal Proceedings Report	2022-06-13	English
Mesoblast to Host KOL Event on Chronic Low Back Pain 3 pages 166.7KB Investor Presentation	2022-06-08	English
6-K Investor Presentation	2022-06-03	English
6-K Interim / Quarterly Report	2022-06-03	English
Third Quarter Financial Results on Form 6-K 96 pages 596.2KB Interim / Quarterly Report 9M 2022	2022-05-31	English
MSB Q3 Financial Results and Operational Highlights 9 pages 348.0KB Interim / Quarterly Report Q3 2022	2022-05-31	English
Third Quarter Results Presentation 44 pages 2.8MB Interim / Quarterly Report Q3 2022	2022-05-31	English
Remestemcel-L Survival Outcomes in COVID-19 ARDS Patients 2 pages 177.4KB Regulatory Filings	2022-05-30	English
Mesoblast Q3 Financial Results Webcast 1 page 112.5 Regulatory Filings	2022-05-30	English
Ceasing to be a substantial holder 23 pages 1.1MB Major Shareholding Notification	2022-05-29	English
6-K Regulatory Filings	2022-05-23	English
Becoming a substantial holder 31 pages 1.3MB Major Shareholding Notification	2022-05-19	English
Litigation Update 2 pages 172.0KB Legal Proceedings Report	2022-05-18	English
6-K Regulatory Filings	2022-05-03	English
Ceasing to be a substantial holder 21 pages 1.1MB Major Shareholding Notification	2022-05-02	English
Ceasing to be a substantial holder 10 pages 142.7KB Major Shareholding Notification	2022-05-01	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 419.1KB Interim / Quarterly Report Q3 2022	2022-04-28	English
6-K Regulatory Filings	2022-04-20	English
Becoming a substantial holder 29 pages 1.3MB Major Shareholding Notification	2022-04-18	English
Appendix 3G and Appendix 3H 21 pages 399.3KB Share Issue/Capital Change	2022-04-13	English
6-K Regulatory Filings	2022-04-11	English
MESOBLAST LIMITED Major Shareholding Notification	2022-04-08	English
Company Secretary Appointment 1 page 138.2KB Board/Management Information	2022-04-05	English
6-K Director's Dealing	2022-03-30	English
Becoming a substantial holder 36 pages 336.0KB Major Shareholding Notification	2022-03-28	English
Initial Director's Interest Notice 2 pages 188.6KB Director's Dealing	2022-03-27	English
Director Appointment 2 pages 174.7KB Board/Management Information	2022-03-23	English
6-K Director's Dealing	2022-03-01	English
6-K Regulatory Filings	2022-02-26	English
6-K Interim / Quarterly Report	2022-02-25	English
Half Yearly Report and Accounts 104 pages 950.4KB Interim / Quarterly Report H1 2022	2022-02-24	English
Second Quarter Results Presentation 42 pages 2.8MB Interim / Quarterly Report Q2 2022	2022-02-24	English
MSB Q2 Financial Results and Operational Highlights 12 pages 591.0KB Interim / Quarterly Report H1 2022	2022-02-24	English
Final Director's Interest Notice 2 pages 184.8KB Director's Dealing	2022-02-24	English
Mesoblast Q2 Financial Results Webcast 1 page 111.9 Regulatory Filings	2022-02-23	English
6-K Regulatory Filings	2022-02-22	English
Ulcerative Colitis & Crohns Results Presented at ECCO 4 pages 187.5KB Regulatory Filings	2022-02-20	English
6-K Regulatory Filings	2022-02-04	English
Mesoblast Appoints Dr Eric Rose as Chief Medical Officer 4 pages 203.6KB Board/Management Information	2022-02-01	English
6-K Regulatory Filings	2022-02-01	English
Appendix 4C Quarterly Activity Report 10 pages 351.5KB Interim / Quarterly Report Q2 2022	2022-01-30	English
6-K Regulatory Filings	2022-01-28	English
MSB Presents at Edison Group Global Healthcare Conference 2 pages 154.9KB Investor Presentation	2022-01-24	English
AUTOMATIC SHELF REGISTRATION STATEMENT Regulatory Filings	2022-01-24	English
6-K Regulatory Filings	2022-01-21	English
MESOBLAST LIMITED Major Shareholding Notification	2022-01-19	English
6-K Regulatory Filings	2022-01-19	English
Proposed issue of securities - MSB 6 pages 29.4KB Capital/Financing Update	2022-01-17	English
Cleansing Notice and Appendix 2A 21 pages 503.9KB Capital/Financing Update	2022-01-17	English
Appendix 3G, Appendix 3H and Appendix 3Y 24 pages 560.2KB Share Issue/Capital Change	2022-01-16	English
Biotech Showcase 2022 Presentation 36 pages 3.5MB Investor Presentation	2022-01-11	English
36-Month Results of Phase 3 Trial in Chronic Low Back Pain 2 pages 165.4KB Investor Presentation	2022-01-11	English
Prospectus for Warrants Related to Oaktree Debt Refinance 45 pages 606.6KB Capital/Financing Update	2022-01-05	English
6-K Regulatory Filings	2022-01-03	English

Filings by year

2026 66 filings
2025 202 filings
2024 141 filings
2023 127 filings
2022 135 filings
2021 101 filings
2020 152 filings
2019 117 filings
2018 107 filings
2017 123 filings
2016 97 filings
2015 92 filings
2014 55 filings
2013 53 filings
2012 34 filings
2011 60 filings
2010 63 filings
2009 56 filings
2008 55 filings
2007 48 filings
2006 62 filings
2005 55 filings
2004 14 filings